CAR- PRISM (PRecision Intervention Smoldering Myeloma)
Clinical trial NCT05767359 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05767359
- Sponsor
- Dana-Farber Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-19
- Primary completion
- 2025-12-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.